Detalhe da pesquisa
1.
Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study).
BMC Palliat Care
; 23(1): 8, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172871